SCIENTURE HOLDINGS, INC. Increase (Decrease) in Other Current Liabilities
SCIENTURE HOLDINGS, INC. (SCNX) reported Increase (Decrease) in Other Current Liabilities of -$5.44 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2025-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2024-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current liabilities for the quarter ending 2024-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2025 was -$5.44K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2024 was -$62.39K, a 2333.00% decline from fiscal 2023.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2023 was $2.79K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current liabilities for fiscal 2020 was -$97.03K.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$5.44K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | -$5.44K 10-Q · filed 2025-11-12 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | -$62.39K 10-K · filed 2026-03-30 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | -$62.39K 10-Q · filed 2025-11-12 | -$54.47K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$62.39K 10-Q · filed 2025-08-12 | -$54.47K derived: sum of 3 quarters · filed 2025-08-12 | -$784.16K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$62.39K 10-Q · filed 2025-05-12 | -$54.47K derived: sum of 2 quarters · filed 2025-05-12 | -$784.16K derived: sum of 3 quarters · filed 2025-05-12 | |
| 2023-12-31 | $7.92K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$721.77K derived: sum of 2 quarters · filed 2025-03-26 | $2.79K 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$729.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$5.13K 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $724.56K 10-Q · filed 2024-08-09 | |||
| 2021-03-31 | -$31.52K 10-Q · filed 2021-04-26 | |||
| 2020-12-31 | -$97.03K 10-K · filed 2021-03-29 | |||
| 2020-03-31 | -$20.97K 10-Q · filed 2021-04-26 | |||
| 2019-12-31 | -$74.63K 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |